Literature DB >> 33814606

Effects of Modified Ultrafiltration on Thromboelastographic Profile after Pediatric Cardiac Surgery.

Umair Abbas1, Rohit S Loomba1, Cynthia Urbas1, Yi Li1, Chawki El-Zein1.   

Abstract

Modified ultrafiltration (MUF) is still used after pediatric cardiopulmonary bypass (CPB) in some pediatric cardiac surgery centers to decrease transfusion requirements. Other potential benefits of MUF include clearance of inflammatory markers and improvement in myocardial function. Our hypothesis is that MUF will hemoconcentrate coagulation factors and improve thromboelastography (TEG) parameters after pediatric CPB. Patients younger than 6 months were prospectively enrolled over a year. TEG was carried out before MUF, after MUF, and after protamine administration. Paired t tests were conducted to compare values pre-MUF and post-MUF as well as post-MUF and post-protamine administration. Thirty patients were enrolled in the study, with 20 (67%) neonates in the cohort. Seven arterial switch operations and nine Norwood procedures were found to be performed among the cohort. Reaction time (R), angle (α), and maximum amplitude (MA) were significantly worse post-MUF compared with pre-MUF (p < .001). They improved significantly after protamine administration compared with post-MUF (p < .001). The amount of fluid removal was significantly associated with a worse post-MUF R, angle, and MA and worse post-protamine administration, angle, and MA but with no effect on post-protamine R. MUF caused worsening of TEG parameters that is reversed by protamine administration. © Copyright 2021 AMSECT.

Entities:  

Keywords:  anticoagulation; blood coagulation; cardiopulmonary bypass; congenital heart diseases; thromboelastography

Year:  2021        PMID: 33814606      PMCID: PMC7995622          DOI: 10.1182/ject-2000051

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  8 in total

Review 1.  Thrombelastography.

Authors:  S V Mallett; D J Cox
Journal:  Br J Anaesth       Date:  1992-09       Impact factor: 9.166

2.  Hemofiltration during cardiopulmonary bypass: the effect on anti-Xa and anti-IIa heparin activity.

Authors:  G J Despotis; V Levine; K S Filos; D Joiner-Maier; J H Joist
Journal:  Anesth Analg       Date:  1997-03       Impact factor: 5.108

3.  The effect of normovolemic modified ultrafiltration on inflammatory mediators, endotoxins, terminal complement complexes and clinical outcome in high-risk cardiac surgery patients.

Authors:  N Papadopoulos; F Bakhtiary; V Grün; C F Weber; C Strasser; A Moritz
Journal:  Perfusion       Date:  2013-02-19       Impact factor: 1.972

4.  Filtration of fentanyl is not the cause of the elevation of arterial blood pressure associated with post-bypass ultrafiltration in children.

Authors:  U M Hodges; S Berg; S K Naik; S Bower; A Lloyd-Thomas; M Elliot
Journal:  J Cardiothorac Vasc Anesth       Date:  1994-12       Impact factor: 2.628

5.  Modified ultrafiltration improves global left ventricular systolic function after open-heart surgery in infants and children.

Authors:  R R Chaturvedi; D F Shore; P A White; M H Scallan; J W Gothard; A N Redington; C Lincoln
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

6.  Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective, randomized clinical trial.

Authors:  G B Luciani; T Menon; B Vecchi; S Auriemma; A Mazzucco
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

7.  Comparison of the effects of red cell separation and ultrafiltration on heparin concentration during pediatric cardiac surgery.

Authors:  G D Williams; C Ramamoorthy; F R Totzek; R L Oakes
Journal:  J Cardiothorac Vasc Anesth       Date:  1997-12       Impact factor: 2.628

Review 8.  Modified ultrafiltration during cardiopulmonary bypass and postoperative course of pediatric cardiac surgery.

Authors:  Mohsen Ziyaeifard; Azin Alizadehasl; Gholamreza Massoumi
Journal:  Res Cardiovasc Med       Date:  2014-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.